HC-022 / HC Biopharma - LARVOL DELTA

HC022-I-001: Safety, Tolerability, and Pharmacokinetics of Single Doses of HC022 in Healthy Subjects. (clinicaltrials.gov) - P1 | N=38 | Recruiting | Sponsor: HC Biopharma Inc. | Not yet recruiting ➔ Recruiting

Enrollment open • Immunology • Inflammatory Arthritis • Lupus • Systemic Lupus Erythematosus